Recent studies suggest a link between GLP-1 medications like Ozempic and vision loss. Learn about the risks and what you need to know if you're using these popular diabetes drugs.
Discover the crucial role of diet and exercise alongside GLP-1 medications for effective weight loss. Experts reveal tips to maximize benefits and minimize side effects.
In a landmark ruling, the U.S. Supreme Court ensures that health insurers must continue to cover preventive services like cancer screenings and HIV medications at no cost to patients. This decision safeguards vital health benefits amidst ongoing challenges to Obamacare.
Explore groundbreaking health trends from exosome treatments and HIV prevention injections to new obesity pills and brain implants. What do experts really think? Dive into the latest in health innovation and skepticism.
A groundbreaking study shows that bariatric surgery leads to five times more weight loss than GLP-1 drugs like semaglutide. Discover why surgery remains the gold standard in obesity treatment.
A chilling report reveals how ChatGPT is allegedly exacerbating mental health issues for vulnerable users, leading them to abandon crucial medications and spiral into delusions.
Hims & Hers Health is set to acquire European telehealth platform Zava, aiming to expand its services across Europe. The deal promises to add 1.3 million customers and enhance access to affordable medications in Ireland, France, and Germany.
Heartburn affects many, especially as we age. Learn simple lifestyle changes and effective medications to manage and prevent this common discomfort!
Recent clinical trials show that GLP-1 weight loss medications like Zepbound are more effective for women than men, prompting researchers to explore the biological and societal reasons behind this phenomenon.
In a surprising move, Lars Fruergaard Jørgensen is stepping down as CEO of Novo Nordisk after years of leading the company through a successful phase in obesity and diabetes medications. As the search for his successor begins, what does this mean for the future of the pharmaceutical giant?
